絞り込み

17396

広告

日本人も「大きな一歩」を 月面着陸へ日米協力 (毎日新聞)

萩生田光一文部科学相と米航空宇宙局(NASA)のジム・ブライデンスタイン長官は10日、オンラインで会談し、米国の有人月面探査計画の日米協力に関する共同宣言に署名...

  1. 腸内ウイルス、治療に一役 酵素が腸炎菌を...
  2. ヒト受精卵使うゲノム編集了承 厚労省と文...
  3. コロナ後遺症、厚労省調査へ (毎日新聞)...
  4. 新型コロナ アビガン有効性結論出ず 藤田...

ニュース一覧

「Mol Cell Oncol[Journal]」の検索結果

809件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Targeting potassium channels and autophagy to defeat chemoresistance.

Mechanisms of spindle bipolarity establishment in acentrosomal human cells.

Distinct mechanisms of mutagenic processing of alternative DNA structures by repair proteins.

Cancer neoantigens and immunogenicity: mutation position matters.

A novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity.

An automated tissue-to-diagnosis pipeline using intraoperative stimulated Raman histology and deep learning.

Mitotic stress-induced secretome primes cancer cells to apoptosis and maximizes paclitaxel response in breast tumors when combined with BCL-xL-targeting BH3 mimetics.

What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation.

Complexities of pharmacogenomic interactions in cancer.

Lysine succinylation and SIRT5 couple nutritional status to glutamine catabolism.

A perspective on DNA damage-induced potentiation of the pentose phosphate shunt and reductive stress in chemoresistance.

Ferroptosis resistance mediated by exosomal release of iron.

Axin2 endometrial stem cells: the source of endometrial regeneration and cancer.

PBRM1 suppresses tumor growth as a novel p53 acetylation reader.

Emerging role of mRNA epitranscriptomic regulation in chemoresistant cancer cells.

Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial disease.

Deep learning: shaping the medicine of tomorrow.

Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer.

Targeting the oncogenic activity of TCF3-HLF in leukemia.

Mapping the breakome reveals tight regulation on oncogenic super-enhancers.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります